"Designing Growth Strategies is in our DNA"

Nuclear Medicine/ Radiopharmaceuticals Market Size, Share & Industry Analysis, By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI101812

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Installed Base of PET/PET-CT Scanners – For Key Countries, 2015 and 2018
    2. Installed Base of Gamma Cameras – for Key Countries, 2018
    3. PET/PET-CT Procedure Volume – for Key Countries, 2018
    4. Reimbursement Scenario in Key Countries
    5. New Product Launches
    6. Key Industry Developments
    7. Pipeline Analysis
  5. Global Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostic Radiopharmaceuticals
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutic Radiopharmaceuticals
    3. Market Analysis, Insights and Forecast – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Diagnostic Radiopharmaceuticals
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutic Radiopharmaceuticals
    3. Market Analysis – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis – By End User
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Diagnostic Radiopharmaceuticals
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutic Radiopharmaceuticals
    3. Market Analysis – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis – By End User
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Diagnostic Radiopharmaceuticals
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutic Radiopharmaceuticals
    3. Market Analysis – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis – By End User
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Diagnostic Radiopharmaceuticals
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutic Radiopharmaceuticals
    3. Market Analysis – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis – By End User
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Lantheus Medical Imaging, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Cardinal Health
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Norgine B.V.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Advanced Accelerator Applications
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Nordion (Nordion (Canada) Inc.)
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Bayer AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Curium
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Bracco Diagnostic Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Jubilant Life Sciences Limited
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. GE Healthcare (General Electric Company)
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

List of Figures:

Figure 1:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Type, 2018 & 2026

Figure 3:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Diagnostic Radiopharmaceuticals, 2015-2026

Figure 4:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Therapeutic Radiopharmaceuticals, 2015-2026

Figure 5:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by PET Radiopharmaceuticals, 2015-2026

Figure 6:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by SPECT Radiopharmaceuticals, 2015-2026

Figure 7:  Global Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Application, 2018 & 2026

Figure 8:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Neurology, 2015-2026

Figure 9:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Cardiology, 2015-2026

Figure 10:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Oncology, 2015-2026

Figure 11:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Others, 2015-2026

Figure 12:  Global Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by End User, 2018 & 2026

Figure 13:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Hospitals & Clinics, 2015-2026

Figure 14:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Diagnostic Centers, 2015-2026

Figure 15:  Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (US$ Mn), by Others, 2015-2026

Figure 16:  Global Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Region, 2018 & 2026

Figure 17:  North America Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Type, 2018 & 2026

Figure 18:  North America Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Type, 2018

Figure 19:  North America Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Application, 2018 & 2026

Figure 20:  North America Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Application, 2018

Figure 21:  North America Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by End User, 2018 & 2026

Figure 22:  North America Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by End User, 2018

Figure 23:  North America Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), By Country, 2018 & 2026

Figure 24:  North America Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), By Country, 2018

Figure 25:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Type, 2018 & 2026

Figure 26:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Type, 2018

Figure 27:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Application, 2018 & 2026

Figure 28:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Application, 2018

Figure 29:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by End User, 2018 & 2026

Figure 30:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by End User, 2018

Figure 31:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 32:  Europe Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), By Country/ Sub-region, 2018

Figure 33:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Type, 2018 & 2026

Figure 34:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Type, 2018

Figure 35:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Application, 2018 & 2026

Figure 36:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Application, 2018

Figure 37:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by End User, 2018 & 2026

Figure 38:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by End User, 2018

Figure 39:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 40:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), By Country/ Sub-region, 2018

Figure 41:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Type, 2018 & 2026

Figure 42:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Type, 2018

Figure 43:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by Application, 2018 & 2026

Figure 44:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by Application, 2018

Figure 45:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Value (US$ Mn), by End User, 2018 & 2026

Figure 46:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Value Share (%), by End User, 2018

Figure 47:  Global Nuclear Medicine/Radiopharmaceuticals Market Share (%), By Company, 2018

List of Tables:

Table 1:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 2:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Diagnostic Radiopharmaceuticals, 2015–2026

Table 3:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by PET Radiopharmaceuticals, 2015–2026

Table 4:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by SPECT Radiopharmaceuticals, 2015–2026

Table 5:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Application, 2015–2026

Table 6:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End User, 2015–2026

Table 7:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End-user, 2015–2026

Table 8:  Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 9:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 10:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Diagnostic Radiopharmaceuticals, 2015–2026

Table 11:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by PET Radiopharmaceuticals, 2015–2026

Table 12:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by SPECT Radiopharmaceuticals, 2015–2026

Table 13:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Application, 2015-2026

Table 14:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 15:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 16:  North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 17:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 18:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Diagnostic Radiopharmaceuticals, 2015–2026

Table 19:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by PET Radiopharmaceuticals, 2015–2026

Table 20:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by SPECT Radiopharmaceuticals, 2015–2026

Table 21:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Application, 2015-2026

Table 22:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 23:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 24:  Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Country/ Sub-region, 2015-2026

Table 25:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 26:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Diagnostic Radiopharmaceuticals, 2015–2026

Table 27:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by PET Radiopharmaceuticals, 2015–2026

Table 28:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by SPECT Radiopharmaceuticals, 2015–2026

Table 29:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Application, 2015-2026

Table 30:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 31:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 32:  Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 33:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Type, 2015-2026

Table 34:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Diagnostic Radiopharmaceuticals, 2015–2026

Table 35:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by PET Radiopharmaceuticals, 2015–2026

Table 36:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by SPECT Radiopharmaceuticals, 2015–2026

Table 37:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by Application, 2015-2026

Table 38:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End User, 2015-2026

Table 39:  Rest of the World Nuclear Medicine/Radiopharmaceuticals Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

 class=
  • Dec, 2019
  • 2018
  • 2015-2017
  • 161

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X